<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Zaman Z</submitter><funding>This work is supported by the Alzheimer’s disease Research Program startup fund to Dr. Sharoar from the Corewell Health East (formally Beaumont Health).</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The unprecedented increase in the older population and ever-increasing incidence of dementia are leading to a "silver tsunami" in upcoming decades. To combat multimorbidity and maintain daily activities, elderly people face a high prevalence of polypharmacy. However, how these medications affect dementia-related pathology, such as Alzheimer's β-amyloid (Aβ) fibrils formation, remains unknown. In the present study, we aimed to analyze the medication profiles of Alzheimer's disease (AD; n = 124), mild cognitive impairment (MCI; n = 114), and non-demented (ND; n = 228) patients to identify highly prevalent drugs and to determine the effects of those drugs on Aβ fibrils formation.&lt;h4>Methods&lt;/h4>Study subjects (≥ 65 years) were recruited from an academic geriatric practice t</pubmed_abstract><journal>BMC neurology</journal><pagination>445</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11562802</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Highly prevalent geriatric medications and their effect on β-amyloid fibril formation.</pubmed_title><pmcid>PMC11562802</pmcid><pubmed_authors>Islam R</pubmed_authors><pubmed_authors>Graham S</pubmed_authors><pubmed_authors>Osentoski T</pubmed_authors><pubmed_authors>Zaman Z</pubmed_authors><pubmed_authors>Sharoar MG</pubmed_authors><pubmed_authors>Falki V</pubmed_authors><pubmed_authors>Koganti B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Highly prevalent geriatric medications and their effect on β-amyloid fibril formation.</name><description>&lt;h4>Background&lt;/h4>The unprecedented increase in the older population and ever-increasing incidence of dementia are leading to a "silver tsunami" in upcoming decades. To combat multimorbidity and maintain daily activities, elderly people face a high prevalence of polypharmacy. However, how these medications affect dementia-related pathology, such as Alzheimer's β-amyloid (Aβ) fibrils formation, remains unknown. In the present study, we aimed to analyze the medication profiles of Alzheimer's disease (AD; n = 124), mild cognitive impairment (MCI; n = 114), and non-demented (ND; n = 228) patients to identify highly prevalent drugs and to determine the effects of those drugs on Aβ fibrils formation.&lt;h4>Methods&lt;/h4>Study subjects (≥ 65 years) were recruited from an academic geriatric practice t</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T22:56:15.065Z</modification><creation>2025-04-06T01:40:22.414Z</creation></dates><accession>S-EPMC11562802</accession><cross_references><pubmed>39543530</pubmed><doi>10.1186/s12883-024-03930-7</doi></cross_references></HashMap>